Metastatic - PowerPoint PPT Presentation


https://www.mediafire.com/file/d57kcf8ylfu6gtp/medium_com_impomed211_sacituzumab

Impomed Healthcare offers crucial insights on Sacituzumab Govitecan 180 mg, a pioneering treatment for metastatic triple-negative breast cancer in India. This comprehensive guide covers its therapeutic benefits, administration guidelines, and strategies for managing side effects. By staying informed

0 views • 11 slides


ASTRO Clinical Guideline on Palliative Radiation Therapy for Symptomatic Bone Metastases

This ASTRO clinical guideline focuses on the use of external beam radiation therapy for palliation of symptomatic bone metastases, emphasizing its efficacy in pain management and local symptom control. Updated evidence and recommendations address the evolving landscape of metastatic cancer treatment

0 views • 32 slides



Understanding the Differences Between Fibrolamellar Carcinoma (FLC) and Hepatocellular Carcinoma (HCC)

Fibrolamellar Carcinoma (FLC) and Hepatocellular Carcinoma (HCC) are distinct liver cancers with important differences in age of onset, underlying causes, diagnostic markers, metastatic patterns, symptoms, treatment options, and outcomes. FLC primarily affects young and healthy individuals with no k

0 views • 4 slides


Optimal First Line Therapy for Metastatic Melanoma: Nivolumab and Relatlimab

Discussing the efficacy and safety of Nivolumab and Relatlimab as a superior first-line therapy option for newly diagnosed metastatic melanoma patients, with comparisons to other treatments based on key endpoints and tolerability data presented at ASCO Annual Meeting.

0 views • 8 slides


1st North West Orthopaedic Oncology Course Overview

Provide an overview of common Musculoskeletal (MSK) oncology pathology assessment, management principles, and preparation for FRCS. The agenda includes topics like soft tissue sarcomas, bone tumors, metastatic bone disease, vivas/cases, and guest speakers sharing valuable insights. Feedback is encou

0 views • 11 slides


Radiology-Pathology Correlation Case Presentation: Ms. DR - Lung Mass Evaluation

Ms. DR, a 62-year-old female with a history of tobacco use, presents with a right lung mass and possible metastatic disease. Imaging reveals a FDG-avid lung mass suspicious for primary malignancy. After obtaining informed consent, a CT-guided core biopsy is performed, showing cohesive, medium-sized

1 views • 16 slides


Evolution of Access to Healthcare Legislation for Critical Illnesses

Legislation has evolved over the years to improve access to healthcare for individuals with critical illnesses like ALS and metastatic breast cancer. Waiting periods were eliminated to ensure timely coverage, with strategic decisions made to involve key stakeholders in the process, ultimately leadin

0 views • 21 slides


Optimal Care Considerations in General Practice Scenarios

A/Prof Justin Tse presents two intriguing GP case studies involving patients with concerning symptoms and management challenges. One case features a 65-year-old male with potential metastatic disease, while the other involves a 55-year-old female with a history of breast cancer and a suspicious thyr

0 views • 8 slides


Comprehensive Guidelines for Medullary Thyroid Carcinoma Management

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor that requires specialized management. This comprehensive guide covers the clinical presentation, diagnosis, genetic aspects, and detailed management strategies for MTC, including surgical options, follow-up evaluation, and systemic the

0 views • 123 slides


Management of Metastatic Malignant Melanoma: Guidelines and Recommendations

The incidence of melanoma is rising rapidly, affecting both men and women. Advanced melanoma management involves multidisciplinary approaches and considerations for limited versus disseminated disease. Surgical resection or systemic therapy is recommended for limited metastatic disease, while dissem

0 views • 48 slides


Metastatic Breast Cancer Treatment and Progression Overview

Mrs. GV, a 78-year-old woman with endocrine-resistant hormone-positive metastatic breast cancer, presented with dyspnea. Her medical history includes chronic fatigue syndrome, hypothyroidism, and hypertension. Disease progression led to dermal and intraocular metastasis, managed with treatments like

0 views • 16 slides


Understanding Metastases in Cancer

Metastases in cancer refer to cancer cells spreading from the original tumor to other parts of the body through the bloodstream, lymphatic system, or direct extension. This content discusses cases of metastatic cancer, including imaging findings, staging, and biopsies, highlighting the challenges in

0 views • 44 slides


Optimal Management of HER2-Positive Breast Cancer: Striving for Consensus

This event on March 2, 2021, gathered experts in the field to discuss the optimal management of HER2-positive breast cancer. The agenda covered topics such as early breast cancer management, treatment sequencing for metastatic disease, and real-life case scenarios. Speakers shared insights on COVID-

0 views • 50 slides


Evaluation of MURR Thermal BNCT Facility for Canine Nasal/Sinus Tumor Treatment

The study evaluates the MURR Thermal BNCT Facility's effectiveness in treating canine nasal/sinus tumors using a phantom. The facility, located at the University of Missouri Research Reactor, offers Boron Neutron Capture Therapy (BNCT) under the direction of Dr. Fred Hawthorne. Key features include

0 views • 21 slides


Early Detection and Monitoring of Colorectal Cancer using ctDNA and Methylation

Blood tests for colorectal cancer (CRC) screening can enhance compliance and options for testing. Markers like ctDNA and aberrantly methylated genes provide potential for early detection and monitoring of CRC recurrence. By combining these markers in plasma samples processed similarly, a more effect

0 views • 36 slides


Understanding Prostate Cancer in India

Prostate cancer is a significant health concern among men, characterized by abnormal cell growth in the prostate gland. This cancer can spread locally or metastasize, leading to different stages such as localized, locally advanced, and metastatic prostate cancer. Dr. Hiralal Chaudhari explains the c

0 views • 14 slides


Advancements in Cholangiocarcinoma Treatment Trials

Recent clinical trials such as TOPAZ-1, KEYNOTE-966, ClarIDHy, and FIGHT-202 have shown promising results in the treatment of cholangiocarcinoma. Trials with immunotherapy and targeted therapy have demonstrated improved overall survival rates, progression-free survival, and objective response rates

0 views • 6 slides


New Horizon for Overcoming Hormonal Treatment Resistance in Metastatic Breast Cancer Patients

Breast cancer, particularly estrogen receptor-positive tumors, poses a significant challenge due to endocrine resistance. While endocrine therapy is effective, resistance can occur in both early and advanced stages of the disease. This presentation discusses novel approaches to address this resistan

0 views • 21 slides


Understanding Pathological Calcification in Veterinary Pathology

Pathological calcification is the abnormal deposition of calcium salts in soft tissues, with two forms - dystrophic and metastatic calcification. Dystrophic calcification occurs in dying tissues, while metastatic calcification reflects a derangement in calcium metabolism. Dystrophic calcification ca

0 views • 11 slides


Comprehensive Review of Mr. A's Metastatic Rectal Cancer Treatment Journey

Mr. A, a 39-year-old man with metastatic rectal cancer, underwent various treatments including chemotherapy, surgery, and maintenance therapy. Despite some side effects and complications, he showed positive tumor responses and clear margins post-surgery. His treatment involved a combination of Folfi

0 views • 27 slides


AJCC/UICC 8th Edition Head and Neck Staging Changes

This content delves into the changes in staging guidelines for head and neck malignancies as per the 8th edition of the AJCC/UICC criteria. It explores the modifications in staging for oropharynx cancer, neck metastatic disease, oral cavity depth of invasion, and cutaneous malignancies. The presenta

0 views • 32 slides


Rational Management of Metastatic Castration-Resistant Prostate Cancer: Treatment Insights and Options

Experts discussed various treatment options for a 60-year-old patient with mCRPC, including switching to Lutetium therapy after progression on Apalutamide. Genetic testing, avoiding back-to-back hormonal therapies, and considering novel AR-blockers like Lutetium-PSMA and PARP inhibitors were highlig

0 views • 6 slides


Therapies and Strategies for ER-Positive, HER2-Negative Metastatic Breast Cancer

Explore the selection and sequence of therapy for ER-positive, HER2-negative metastatic breast cancer, along with novel agents and strategies under evaluation. Learn about cases of postmenopausal women with metastatic breast cancer, CDK4/6 inhibitors, and the impact of targeted therapies on patient

0 views • 23 slides